Werewolf Therapeutics Inc
(NASDAQ:HOWL)
$2.12
-0.02[-0.93%]
Last update: 6:00PM (Delayed 15-Minutes)
Get Real Time Here
$2.12
0[0.00%]
Open2.140Close2.140
Vol / Avg.14.635K / 38.666KMkt Cap75.595M
Day Range2.140 - 2.24052 Wk Range1.400 - 4.950

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Werewolf Therapeutics Stock (NASDAQ:HOWL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$32.00

Lowest Price Target1

$8.00

Consensus Price Target1

$16.79

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
80000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • Wedbush
  • EF Hutton
  • B of A Securities
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Werewolf Therapeutics

All Ratings (22)

Upgrades (0)

Downgrades (0)

Initiations (7)

Q

What is the target price for Werewolf Therapeutics (HOWL)?

A

The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by HC Wainwright & Co. on September 19, 2023. The analyst firm set a price target for $15.00 expecting HOWL to rise to within 12 months (a possible 607.55% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Werewolf Therapeutics (HOWL)?

A

The latest analyst rating for Werewolf Therapeutics (NASDAQ: HOWL) was provided by HC Wainwright & Co., and Werewolf Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Werewolf Therapeutics (HOWL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Werewolf Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Werewolf Therapeutics was filed on September 19, 2023 so you should expect the next rating to be made available sometime around September 19, 2024.

Q

Is the Analyst Rating Werewolf Therapeutics (HOWL) correct?

A

While ratings are subjective and will change, the latest Werewolf Therapeutics (HOWL) rating was a reiterated with a price target of $0.00 to $15.00. The current price Werewolf Therapeutics (HOWL) is trading at is $2.12, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.